Pharmaceuticals
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64
06/11/2019 - Gene variation protects against diabetes
A gene linked to type 2 diabetes may offer clues to new therapies, British researchers say. More
01/11/2019 - Two hormones key to prostate cancer risk
Men have an increased risk of developing prostate cancer if their blood has high levels of free testosterone and a growth hormone, a conference hears today. More
30/10/2019 - Caution urged around antibiotic threat
The language used to describe antimicrobial resistance is counterproductive and unlikely to cut the overuse, experts say today. More
30/10/2019 - Hope for Alzheimer’s treatment opportunity
Scientists working on progressive neurodegeneration diseases have found that some of the changes could be halted during an "under-appreciated time window". More
30/10/2019 - Peanut allergy immunotherapy not a cure
Immunotherapy for peanut allergy can provide some protection – but does not offer a permanent cure, according to research published today. More
23/10/2019 - Blood pressure drugs best taken at bedtime?
Hypertensive patients can have better control of their condition, and lower risk of adverse events by taking medications last thing at night rather than in the morning, researchers report today. More
21/10/2019 - Antibiotics resistance doubles in 20 years
Resistance to antibiotics used for treating H. Pylori infections has more than doubled in 20 years, a European conference has heard. More
15/10/2019 - Cannabidiol trial for Parkinson's-related psychosis
A £1.2 million phase II trial is to begin early next year into the effectiveness of cannabidiol in people with Parkinson’s-related psychosis. More
09/10/2019 - Antimicrobial resistance battle faltering
The battle against antimicrobial resistance is faltering in the world's poorest countries, a think-tank has warned. More
09/10/2019 - Study challenges paclitaxel coating fears
There is no evidence of increased mortality risk from the use of paclitaxel coated devices, according to an analysis published today. More
02/10/2019 - Oral steroid warning for asthma patients
Too many people with severe asthma are at risk through the use of oral steroids, a major European conference will hear today. More
02/10/2019 - Novel test for complications of pneumonia
A new test has been developed to identify pneumonia patients who may be at risk of respiratory failure or sepsis, it was announced today. More
01/10/2019 - Backing for asthma triple therapy inhaler
A triple therapy inhaler may be the best way to help patients with severe and uncontrolled asthma, according to the findings of a major international study. More
30/09/2019 - Placebos may not be placebo - analysis
Clinical researchers should give more information about placebos - as sometimes they may be more active than described, according to an analysis published today. More
19/09/2019 - Cancer drug benefits exaggerated - claim
The benefits of new cancer drugs continue to be exaggerated in reporting of key trials, it was alleged today. More
18/09/2019 - Cancer therapy response 'eNose' test
Researchers have created an ‘electronic nose’ that can effectively predict individual patient responses to immunotherapy, it was announced today. More
18/09/2019 - Method of breath-holding for radiotherapy success
Researchers say they are perfecting a breath-holding technique that will allow cancer patients to stay completely still during extended radiotherapy sessions. More
17/09/2019 - Puberty and menopause link to type 2 diabetes risk
Having a longer menstrual cycle and using the contraceptive pill are linked to an increased risk of developing type 2 diabetes, French researchers claim today (17 September 2019). More
06/09/2019 - Hope for proton therapy after drug breakthrough
Cancer patients needing proton therapy could benefit from more effective treatment after scientists in Norway discovered that light-activated drugs transform the treatment. More
04/09/2019 - Statins benefit peripheral arterial disease
Adhering to statin treatment can reduce the risk of death among patients with peripheral arterial disease, Swiss researchers have reported. More
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64
Printer friendly page